Publications in collaboration with researchers from Heinrich Heine University Düsseldorf (24)

2024

  1. Architecture, Function, Regulation, and Evolution of α-Glucans Metabolic Enzymes in Prokaryotes

    Chemical Reviews, Vol. 124, Núm. 8, pp. 4863-4934

2023

  1. Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases

    The Lancet Rheumatology

  2. In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study

    The Lancet Respiratory Medicine, Vol. 11, Núm. 2, pp. 151-162

  3. Iodine supplementation for preventing iodine deficiency disorders in children and adolescents

    Cochrane Database of Systematic Reviews, Vol. 2023, Núm. 4

2021

  1. European League against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 6, pp. 775-781

  2. What are the topics you care about making trials in lupus more effective? Results of an Open Space meeting of international lupus experts

    Lupus Science and Medicine, Vol. 8, Núm. 1

2020

  1. An integrative omics approach reveals involvement of BRCA1 in hepatic metastatic progression of colorectal cancer

    Cancers, Vol. 12, Núm. 9, pp. 1-24

  2. Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 10, pp. 1333-1339

  3. The Rare IL22RA2 Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple Sclerosis

    Cells, Vol. 9, Núm. 1

2019

  1. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 9, pp. 1151-1159

  2. Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

    The Lancet Neurology, Vol. 18, Núm. 9, pp. 845-856

  3. The Mycobacterium tuberculosis capsule: A cell structure with key implications in pathogenesis

    Biochemical Journal, Vol. 476, Núm. 14, pp. 1995-2016

2016

  1. Analysis of plasminogen genetic variants in multiple sclerosis patients

    G3: Genes, Genomes, Genetics, Vol. 6, Núm. 7, pp. 2073-2079

  2. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. Genome-wide significant association with seven novel multiple sclerosis risk loci

    Journal of Medical Genetics, Vol. 52, Núm. 12, pp. 848-855

2013

  1. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): A randomised trial

    The Lancet, Vol. 382, Núm. 9890, pp. 397-408

  2. Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk

    Journal of Medical Genetics, Vol. 50, Núm. 3, pp. 140-143

  3. MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis

    Brain, Vol. 136, Núm. 6, pp. 1778-1782

2012

  1. A European multicentre photopatch test study

    British Journal of Dermatology, Vol. 166, Núm. 5, pp. 1002-1009